Patient Testimony Highlights Difficulties Of Pain Drug Development, US FDA Regulation Of Opioids

At patient-focused drug development meeting, many patients explained that opioids gave them functionality versus side effects such as suicidal ideation and fatigue that come with other treatments.

More from US FDA

More from Agency Leadership